Clinical Trial Update: A Trial to Investigate the Safety and Pharmacokinetics of GRT6019 in Healthy Male Participants [Phase 1]

View source ↗

Summary

This is a Phase 1 trial evaluating the safety and pharmacokinetics of GRT6019 in healthy male participants for Duchenne muscular dystrophy; the trial is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• GRT6019

Snippet

Sponsor: Grünenthal GmbH | Conditions: Duchenne Muscular Dystrophy (DMD) | Phase 1 | Status: ACTIVE_NOT_RECRUITING